Palliative chemotherapy for patients with advanced cancer might offer modest survival benefits, but patients are often not given complete information about these benefits, which can hinder their ability to make an informed decision Medscape Medical News
Pathwork Tissue of Origin Test is a gene expression test using microarray technology to help diagnose the primary site of tumors of unclear origin. Medscape Medical News
Dr. Anita Hill, who specializes in paroxysmal nocturnal hemoglobinuria (PNH) and in marrow failure, discusses the effects on quality of life of new therapies.
Peter Hillmen, the modern father of this field, presents the treatment of thrombosis and thrombotic complications in patients with paroxysmal nocturnal hemoglobinuria (PNH).
Dr. Anita Hill, who specializes in paroxysmal nocturnal hemoglobinuria (PNH) and in marrow failure, discusses the effects on quality of life of new therapies.
Questions and answers for this paroxysmal nocturnal hemoglobinuria symposium: clinicians will better understand how to make a diagnosis, comprehend what is happening in patients, and advise treatment.
Questions and answers for this paroxysmal nocturnal hemoglobinuria symposium: clinicians will better understand how to make a diagnosis, comprehend what is happening in patients, and advise treatment.
Read our clinically focused reviews of results from AUA 2008 on a broad range of topics: prostate cancer, BPH, incontinence, and sexual function. Medscape Urology
A 16-year-old male with a history of testicular cancer presents with blurry vision in his right eye. What might be the diagnosis? Medscape Ophthalmology
Outline issues and complications related to paroxysmal nocturnal hemoglobinuria (PNH), and review current and emerging treatment regimens for patients with PNH.
